These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28430297)

  • 41. Nontuberculous Mycobacterial Infections Associated With Left Ventricular Assist Devices in 3 Patients.
    Singh M; Krishnan M; Ruiz ME; Sheikh FH
    Tex Heart Inst J; 2022 Jul; 49(4):. PubMed ID: 35838643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical manifestations and management of left ventricular assist device-associated infections.
    Nienaber JJ; Kusne S; Riaz T; Walker RC; Baddour LM; Wright AJ; Park SJ; Vikram HR; Keating MR; Arabia FA; Lahr BD; Sohail MR;
    Clin Infect Dis; 2013 Nov; 57(10):1438-48. PubMed ID: 23943820
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of body mass index and device type on infection in left ventricular assist device support beyond 30 days.
    Martin SI; Wellington L; Stevenson KB; Mangino JE; Sai-Sudhakar CB; Firstenberg MS; Blais D; Sun BC
    Interact Cardiovasc Thorac Surg; 2010 Jul; 11(1):20-3. PubMed ID: 20388700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgical infection prophylaxis prior to left ventricular assist device implantation: A survey of clinical practice.
    Mourad A; Arif S; Bishawi M; Milano C; Miller RA; Maskarinec SA
    J Card Surg; 2020 Oct; 35(10):2672-2678. PubMed ID: 32678965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implantable LVAD infections: implications for permanent use of the device.
    McCarthy PM; Schmitt SK; Vargo RL; Gordon S; Keys TF; Hobbs RE
    Ann Thorac Surg; 1996 Jan; 61(1):359-65; discussion 372-3. PubMed ID: 8561605
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of percutaneous driveline infection after left ventricular assist device implantation: prophylactic antibiotics are not necessary.
    Stulak JM; Maltais S; Cowger J; Joyce LD; Daly RC; Park SJ; Aaronson KD; Pagani FD
    ASAIO J; 2013; 59(6):570-4. PubMed ID: 24172262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of HeartMate III-LVAD driveline infection by negative pressure wound therapy: Result of our case series.
    Cikirikcioglu M; Ponchant K; Murith N; Meyer P; Yilmaz N; Huber C
    Int J Artif Organs; 2021 Nov; 44(11):912-916. PubMed ID: 34558333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes in patients receiving HeartMate II versus HVAD left ventricular assist device as a bridge to transplantation.
    Sabashnikov A; Mohite PN; Zych B; Popov AF; Fatullayev J; Zeriouh M; Hards R; Sáez DG; Capoccia M; Choi YH; Wahlers T; De Robertis F; Bahrami T; Amrani M; Simon AR
    Transplant Proc; 2014 Jun; 46(5):1469-75. PubMed ID: 24935315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of chlorhexidine gluconate intolerance on driveline infection during chronic HeartMate II left ventricular assist device support.
    Son AY; Stein LH; DeAnda A; Katz SD; Smith DE; Reyentovich A; Balsam LB
    Int J Artif Organs; 2017 Jan; 39(11):570-574. PubMed ID: 28085173
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic volume performs better than SUVmax in the detection of left ventricular assist device driveline infection.
    Avramovic N; Dell'Aquila AM; Weckesser M; Milankovic D; Vrachimis A; Sindermann JR; Wenning C
    Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1870-1877. PubMed ID: 28547176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Left ventricular assist device driveline infections.
    Pereda D; Conte JV
    Cardiol Clin; 2011 Nov; 29(4):515-27. PubMed ID: 22062200
    [TBL] [Abstract][Full Text] [Related]  

  • 52. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices.
    Radovancevic B; Vrtovec B; de Kort E; Radovancevic R; Gregoric ID; Frazier OH
    J Heart Lung Transplant; 2007 Aug; 26(8):815-8. PubMed ID: 17692785
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of Vitamin D Level on Clinical Outcomes in Patients Undergoing Left Ventricular Assist Device Implantation.
    Obeid FA; Yost G; Bhat G; Drever E; Tatooles A
    Nutr Clin Pract; 2018 Dec; 33(6):825-830. PubMed ID: 29603408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Driveline angle is crucial for preventing driveline infection in patients with HeartMate II device.
    Matsumoto Y; Fukushima S; Shimahara Y; Yamashita K; Kawamoto N; Kuroda K; Seguchi O; Yanase M; Fukushima N; Shimizu H; Kobayashi J; Fujita T
    J Artif Organs; 2019 Mar; 22(1):37-43. PubMed ID: 30298341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pexy of intraperitoneal LVAD driveline to relieve small bowel obstruction.
    Cresse SM; Urrechaga EM; Cioci AC; Banerjee MN; Cahill A; Lieberman HM
    J Card Surg; 2020 Feb; 35(2):492-494. PubMed ID: 31794108
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Minimum inhibitory concentration changes in relapsed left ventricular assist device driveline infections.
    Lines TH; Sabato LA; Nesbitt WJ; Moretz JD; Brinkley DM; Satyanarayana G
    Int J Artif Organs; 2020 Jul; 43(7):494-499. PubMed ID: 31964206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perioperative blood product use: a comparison between HeartWare and HeartMate II devices.
    Haglund NA; Davis ME; Tricarico NM; Ahmad RM; DiSalvo TG; Keebler ME; Schlendorf KH; Wigger MA; Stulak JM; Maltais S
    Ann Thorac Surg; 2014 Sep; 98(3):842-9. PubMed ID: 25085559
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Obesity as a Risk Factor for Consideration for Left Ventricular Assist Devices.
    Mohamedali B; Yost G; Bhat G
    J Card Fail; 2015 Oct; 21(10):800-5. PubMed ID: 26093334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A retrospective study of left ventricular assist device-related infections.
    Bentz B; Hupcey JE; Polomano RC; Boehmer JP
    J Cardiovasc Manag; 2004; 15(1):9-16. PubMed ID: 14976692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.